Reclazepam
From Wikipedia, the free encyclopedia
Jump to: navigation, search
 |
|
| Systematic (IUPAC) name | |
|---|---|
|
2-[7-chloro-5-(2-chlorophenyl)-2,3-dihydro-1,4-benzodiazepin-1-yl]-1,3-oxazol-4-one
|
|
| Identifiers | |
| CAS Number | 76053-16-2  Y |
| ATC code | none |
| PubChem | CID 3052777 |
| ChemSpider | 2314554 Y |
| UNII | YJL42911RA Y |
| KEGG | D05710 Y |
| Chemical data | |
| Formula | C18H13Cl2N3O2 |
| Molar mass | 374.221 g/mol |
| 3D model (Jmol) | Interactive image |
|
|
|
|
| (verify) | |
Reclazepam[1] is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those produced by other benzodiazepine derivatives, and has a short duration of action.[2]
See also[edit]
References[edit]
- ^ US Patent 4208327
- ^ Pscyhotropics.dk (20 January 1986). "reclazepam". Retrieved 24 August 2009.
 |
This sedative-related article is a stub. You can help Wikipedia by expanding it. |
